Portal:CPTAC/FeaturedPathways
From WikiPathways
(Difference between revisions)
| Line 11: | Line 11: | ||
|width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}} | |width=100px|{{#pwimage:Pathway:WP3|250px||Transcriptional activation by NRF2}} | ||
|width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}} | |width=100px|{{#pwimage:Pathway:WP4018|250px||Pathways in Renal Cancer}} | ||
| + | |- | ||
| + | |width=100px|{{#pwImage:Pathway:WP3301|250px||MFAP5-mediated ovarian cancer cell motility and invasiveness}} | ||
|} | |} | ||
Revision as of 22:54, 4 October 2017
|
Image does not exist TCA Cycle Nutrient Utilization and Invasiveness of Ovarian Cancer |
Image does not exist PDGFR-beta pathway Zhang, et al. Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer |
Image does not exist Bladder Cancer |
Image does not exist EPO Receptor Signaling |
|
Image does not exist ErbB Signaling Pathway |
Image does not exist Interferon type I signaling pathways |
Image does not exist Transcriptional activation by NRF2 |
Image does not exist Pathways in Renal Cancer |
|
Image does not exist MFAP5-mediated ovarian cancer cell motility and invasiveness |
